Respiratory function
[대역어] 호흡기능
[용어속성] Term
[용어속성] Term
Safety and efficacy of Ayurvedic interventions and Yoga on long term effects of COVID-19: A structured summary of a study protocol for a randomized controlled trial
COVID-19의 장기적인 영향에 대한 아유르베다 중재 및 요가의 안전성 및 효능: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
Acute coronary syndrome
acute respiratory distress
acute respiratory distress syndrome
Adverse
Adverse drug reaction
Agastya
Agastya Haritaki
alcoholism
ARDS
Arm
arrhythmia
Ashwagandha
Atrial fibrillation
Ayurveda
baseline
biochemical
blinded
Blinding
calculated
Care
CBC
change
chronic respiratory disease
clinical
clinical assessment
Clinical Management Protocol
comparator
completion
Computed tomography
conducted
confidence
confidence level
coronary syndrome
COVID 19
COVID-19
COVID-19 case
Critically ill
Critically ill patient
critically ill patients
CTRI
D-dimer
depressive
diabetes
Diabetes Mellitus
diagnosed
Diego
disease
dropout rate
drug
drug reaction
Effect
Efficacy
element
eligible
enrolled
enrolment
evening
excluded
exploratory study
generate
GMP
Government
Government of India
group
hematological
hepatic disease
HIV
HRCT
hs-CRP
hypersensitivity
IgM antibodies
IgM antibody
illness
illnesses
immunosuppressive medications
Impact
impaired cognition
index
India
intensive care
intensive care unit
Intervention
invasive respiratory support
journal
Laboratory parameters
lactating women
Level
life
long term
long-COVID
malignancy
management
motor neuron
motor neuron disease
multiple sclerosis
Myocardial infarction
negative RT-PCR
number
objective
Open-label
open-label design
outcome
parallel group
parameter
participant
Participants
past history
Patient
Pharmaceutical Company
Pittsburgh
positive RT-PCR
Post-COVID
pregnant
Previous studies
protocol
provided
pulmonary
Pulmonary function test
pulmonary tuberculosis
Quality
Quality of life
random
randomised
randomised controlled trial
Randomized
Randomized controlled trial
recruitment
Registered
registry
rehabilitation
renal
renal disease
respiratory
Respiratory disease
respiratory distress
Respiratory function
Safety
Sample
Sample size
SARS CoV
SARS CoV-2
SARS-CoV-2
scale
Science
score
secondary
Secondary outcomes
Sex
Shortness of breath
Sleep
sleep quality
SPSS
Standard deviation
status
stroke
study duration
study group
study period
Study protocol
Subjective
substance dependence
supplementary material
syndrome
Tablet
the study group
timeline
Trial
Trial registration
Tuberculosis
Version
warm water
water
website
WHO
yoga
[DOI] 10.1186/s13063-021-05326-1 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05326-1 PMC 바로가기 [Article Type] Letter
Pulmonary long-term consequences of COVID-19 infections after hospital discharge
퇴원 후 COVID-19 감염의 폐 장기 결과
Article
Published on
Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 바이오마커,
Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 바이오마커,
[키워드] 6-minute walk test
6MWT
95%CI
abnormality
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Adhesion Molecule
Biomarker
Biomarkers
carbon monoxide
Chest computed tomography
Comorbidities
Computed tomography
consequence
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 hospitalization
COVID-19 infection
diffusing
diffusing capacity
diffusion
diffusion capacity
discharge
discharged patient
discharged patients
Effect
epidemiological
evaluated
expiratory
forced expiratory volume
forced vital capacity
FVC
group
hospital
hospital discharge
Hospital stay
Hospitalization
identify
Inflammation
information
inhibitor
inhibitors
Intracellular
Intracellular adhesion molecule
IQR
laboratory parameter
Laboratory parameters
laboratory-confirmed
Lactate
lactate dehydrogenase
Limited
Lung diffusion capacity
Lung function
matrix metalloproteinases
median
medical histories
Multivariate analysis
onset of symptom
Osteoprotegerin
Patient
patients
performed
plasminogen
Plasminogen activator inhibitor
Proteases
pulmonary
Pulmonary function
Pulmonary function tests
Real-time PCR
receptor
receptors
recovering from COVID-19
recruited
respiratory
Respiratory function
Respiratory function test
Respiratory function tests
RT-PCR
SARS-CoV-2
SARS-CoV-2-infected patient
SARS-CoV-2-infected patients
screened
serum
serum lactate
severe acute respiratory syndrome Coronavirus
severe disease
severe SARS-CoV-2
severity
Spanish
Sputum sample
sputum samples
survivor
Symptom
symptom onset
Tissue Inhibitor
Tissue inhibitor of matrix metalloproteinases
tomography
virus
vital capacity
Volume
were measured
[DOI] 10.1016/j.cmi.2021.02.019 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.cmi.2021.02.019 PMC 바로가기 [Article Type] Article
A follow-up study of respiratory and physical function after discharge in patients with redetectable positive SARS-CoV-2 nucleic acid results following recovery from COVID-19
Article
[키워드] COVID-19
Physical function
Redetectable positive
rehabilitation
Respiratory function
SARS-CoV-2
[DOI] 10.1016/j.ijid.2021.04.020 PMC 바로가기
[DOI] 10.1016/j.ijid.2021.04.020 PMC 바로가기
Matched cohort study on the efficacy of tocilizumab in patients with COVID-19
Research article
[키워드] adjusted
Admission
analyzed
baseline
clinical benefit
clinical variables
Cohort
cohort study
confounders
control patient
control patients
coronavirus
COVID-19
discharge
disease
Efficacy
Evidence
group
hospital
increment
inspired oxygen fraction
logistic regression models
lung involvement
Matched
Mortality
no difference
not significantly different
observational study
other treatment
Patient
patients
patients treated
patients with COVID-19
Primary outcomes
Respiratory function
Result
risk factor
SAFI
SARS-CoV-2
secondary outcome
Spain
sub-cohort
Support
Tocilizumab
Treatment
[DOI] 10.1016/j.onehlt.2021.100214 [Article Type] Research article
[DOI] 10.1016/j.onehlt.2021.100214 [Article Type] Research article
Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia
Article
[키워드] 95% CI
Admission
clinical trial
Coagulopathy
COVID-19
COVID-19 disease
death
dosage
Effect
evaluate
evaluated
female
Hospital admission
Interaction
intubation
IQR
LMWH
low molecular weight
median age
Mild
Moderate COVID-19
PaO
Patient
patients with COVID-19
Pneumonia
primary endpoint
Probability
progression
Prophylactic
receiving
reduce
Respiratory function
risk
Rome
SARS-CoV-2
SARS-COV-2 infection
significantly
Stage
therapeutic
translate
viral infection
[DOI] 10.1038/s41598-021-90713-6 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41598-021-90713-6 PMC 바로가기 [Article Type] Article
Cumulative Risks from Stressor Exposures and Personal Risk Factors in the Workplace: Examples from a Scoping Review
Review
Published on
Journal: International Journal of Environmental Research an [Category] Coronavirus, SARS,
Journal: International Journal of Environmental Research an [Category] Coronavirus, SARS,
[키워드] approach
assessment
cancers
Characteristics
Combination
combined exposure
condition
conditions
COVID-19 pandemic
cumulative risk
cumulative risk assessment
determinant
determinants
disease
Diseases
dysfunction
employment
essential worker
estimate
Evidence
example
exposure
Factor
Health
health risk assessment
Health status
hearing loss
IMPROVE
limit
management
menstrual
mental health
multiple determinants of health
occupational health
outcome
physical
physical agent
progressed
PROTECT
Protecting
Protective
psychosocial stressor
public health
Respiratory function
review
risk
Risk factors
Stressor
while
Workplace
worsened
[DOI] 10.3390/ijerph18115850 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/ijerph18115850 PMC 바로가기 [Article Type] Review
COVID-19: breaking down a global health crisis
Review
[키워드] accelerated
acute respiratory distress
characteristic
Complication
coronavirus
Coronavirus disease 2019
cough
country
COVID-19
COVID-19 pandemic
death
Dexamethasone
disease
dry cough
effective
effort
flu-like symptoms
Global & Public Health
headache
Health
humans
Hydroxychloroquine
Immunocompromised
include
Infection
Infectious diseases
interferon
maintaining
Manifestations
Masks
Measures
MERS
Middle East
Most patient
pandemic
Patient
Patient management
Personal protective equipment
Pneumonia
Precaution
precautions
Remdesivir
respiratory
Respiratory droplets
Respiratory function
risk
Ritonavir
RNA
SARS-CoV-2
Septic shock
single-stranded
sneezes
social distancing
spike glycoprotein
Spread
supportive care
syndrome
the Coronaviridae
Tocilizumab
vaccination
virus
with COVID-19
[DOI] 10.1186/s12941-021-00438-7 PMC 바로가기 [Article Type] Review
[DOI] 10.1186/s12941-021-00438-7 PMC 바로가기 [Article Type] Review
Comparing COVID-19 and Influenza Presentation and Trajectory
Medicine
[키워드] Acute respiratory infection
addition
Admission
affected
age
Analysis
analyzed
Biomarker
Biomarkers
Blood
body mass index
Campus
Coagulation
Comorbidity
COVID-19
COVID-19 group
COVID-19 patient
COVID-19 patients
Critical
demographics
disease
disease trajectory
electronic medical record
ENhance
functions
Glucose
group
Haifa
help
Hospitalization
Hospitalized
immune response
in-hospital mortality
include
individual
Influenza
intrinsic
knowledge
lab
metabolism
neutrophil
Older
Other
Pathogenesis
Patient
patients
presentation
Prevalence
Pulse rate
Respiratory function
Respiratory illness
respiratory illnesses
SARI
suffered
trajectory
Treatment
variable
virulence
vital sign
was performed
White blood cell
[DOI] 10.3389/fmed.2021.656405 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.656405 PMC 바로가기 [Article Type] Medicine
SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020
Research Article
[키워드] baseline
carried
Clinical course
cohort study
Contact
control group
controls
cough
Course
COVID-19
disease
Dyspnea
fibrosis
Follow-up
groups
Hospitalized
ICU admission
Infection
Italy
lung transplant
Mild
molecular
multicentre
non-invasive ventilation
objective
Organ transplant
outcome
Patient
patients
positive
Prospective Study
reported
reported symptom
reported symptoms
required
Respiratory function
Result
SARS-CoV-2
SARS-COV-2 infection
Symptom
tested
the disease
[DOI] 10.1371/journal.pone.0251527 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0251527 PMC 바로가기 [Article Type] Research Article